Synthesis, Antibacterial Effects, and Toxicity of Licochalcone C

Author:

Ozanique Patrick Rômbola1,Helena Alvaro Luiz1,Menezes Ralciane de Paula2,Gonçalves Daniela Silva2ORCID,Santiago Mariana Brentini2ORCID,Dilarri Guilherme3ORCID,Sardi Janaína de Cássia Orlandi4ORCID,Ferreira Henrique3ORCID,Martins Carlos Henrique Gomes2ORCID,Regasini Luis Octávio1ORCID

Affiliation:

1. Department of Chemistry and Environmental Sciences, Institute of Biosciences, Humanities and Exact Sciences, São Paulo State University (Unesp), São José do Rio Preto 15054-000, SP, Brazil

2. Department Microbiology, Institute of Biomedical Sciences, Federal University of Uberlândia (UFU), Umuarama 38405-320, MG, Brazil

3. Department of Biochemistry and Microbiology, Institute of Biosciences, São Paulo State University (Unesp), Rio Claro 13506-900, SP, Brazil

4. Dental Research Division, Guarulhos University, Guarulhos 07023-070, SP, Brazil

Abstract

Drug-resistant bacteria constitute a big barrier against current pharmacotherapy. Efforts are urgent to discover antibacterial drugs with novel chemical and biological features. Our work aimed at the synthesis, evaluation of antibacterial effects, and toxicity of licochalcone C (LCC), a naturally occurring chalcone. The synthetic route included six steps, affording a 10% overall yield. LCC showed effects against Gram-positive bacteria (MIC = 6.2–50.0 µg/mL), Mycobacterium species (MIC = 36.2–125 µg/mL), and Helicobacter pylori (MIC = 25 µg/mL). LCC inhibited the biofilm formation of MSSA and MRSA, demonstrating MBIC50 values of 6.25 μg/mL for both strains. The investigations by fluorescence microscopy, using PI and SYTO9 as fluorophores, indicated that LCC was able to disrupt the S. aureus membrane, similarly to nisin. Systemic toxicity assays using Galleria mellonella larvae showed that LCC was not lethal at 100 µg/mL after 80 h treatment. These data suggest new uses for LCC as a compound with potential applications in antibacterial drug discovery and medical device coating.

Funder

Coordination of Superior Level Staff Improvement

National Council for Scientific and Technological Development

São Paulo Research Foundation

Publisher

MDPI AG

Reference63 articles.

1. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis;Murray;Lancet,2022

2. World Health Organization (2020). Global 2020 Antibacterial Agents in Clinical and Preclinical Development: An Overview and Analysis, WHO. Available online: https://www.who.int/publications/i/item/9789240021303/.

3. Bacterial Biofilms: A Common Cause of Persistent Infections;Costerton;Science,1999

4. Natural Products as Sources of New Drugs over the Nearly Four Decades from January 1981 to September 2019;Newman;J. Nat. Prod.,2020

5. Dai, J., Han, R., Xu, Y., Li, N., Wang, J., and Dan, W. (2020). Recent progress of antibacterial natural products: Future antibiotics candidates. Bioorg. Chem., 101.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3